TM-Logo-Navy.png
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Class Clinical Program Operations
26 juin 2024 20h00 HE | Novotech
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Class Clinical Program Operations
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
26 juin 2024 16h41 HE | Novotech
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
22 juin 2024 20h45 HE | Novotech
BOSTON, June 22, 2024 (GLOBE NEWSWIRE) -- Novotech, a global full-service clinical Contract Research Organization (CRO) specializing in partnering with biotech companies to expedite the development...
Novotech Publishes Report on Research into Endometrial Cancer, a Leading Cause of Gynecology Malignancy Mortality
Novotech Publishes Report on Research into Endometrial Cancer, a Leading Cause of Gynecology Malignancy Mortality 
20 juin 2024 22h53 HE | Novotech
BOSTON, June 20, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of...
TM-Logo-Navy.png
Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment
03 juin 2024 09h35 HE | Novotech
Novotech launches a dedicated early-phase strategic delivery unit focussed on leveraging the unique advantage of ANZ for early-phase clinical development
TM-Logo-Navy.png
Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)
29 mai 2024 22h43 HE | Novotech
Novotech today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL).
TM-Logo-Navy.png
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston
22 mai 2024 20h11 HE | Novotech
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston
TM-Logo-Navy.png
Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team
02 mai 2024 17h00 HE | Novotech
Novotech CRO appoints Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC).
Acute Myeloid Leukemia (AML)
Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs
10 avr. 2024 22h37 HE | Novotech
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data
Cystic Fibrosis (CF)
Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning 
10 avr. 2024 22h33 HE | Novotech
The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density, and patient recruitment data.